Enlarged breast tissue in men, called gynecomastia, is almost always caused by a shift in the balance between estrogen and testosterone. Every male body produces some estrogen, but when estrogen levels rise relative to testosterone, breast tissue can grow. This hormonal shift can happen naturally at certain life stages, or it can be triggered by medications, health conditions, excess body fat, or substance use.
The Hormonal Mechanism Behind It
Male breast tissue contains estrogen receptors just like female breast tissue does. Normally, testosterone keeps estrogen’s effects in check. But when the ratio tips in estrogen’s favor, those receptors get activated and the tissue starts growing. This can happen in two basic ways: estrogen goes up, or testosterone goes down. Sometimes both happen at once.
One key player is an enzyme called aromatase, which converts testosterone into estrogen. Aromatase lives in fat tissue, the liver, and other organs. Anything that increases aromatase activity, or anything that lowers testosterone production, shifts the ratio and can trigger breast growth. The body also produces a protein (called SHBG) that binds to sex hormones in the blood. This protein grabs onto testosterone more tightly than estrogen, so when SHBG levels rise, more free estrogen is available to act on breast tissue even if total hormone levels look normal.
It’s Extremely Common at Three Life Stages
Gynecomastia has three natural peaks: in newborns, during puberty, and in older men. Newborns often have temporarily swollen breast tissue from their mother’s estrogen, which fades within weeks. In older men, testosterone gradually declines while body fat (and its aromatase activity) tends to increase, creating the classic ratio shift.
Puberty is the most familiar trigger. Hormones fluctuate dramatically during adolescence, and estrogen levels can temporarily outpace testosterone. Estimates of how many teenage boys experience some degree of breast enlargement vary widely, from 4% to as high as 69% depending on how it’s measured. A large study of over 596,000 adolescents aged 12 to 15 found clinically diagnosed gynecomastia in about 1% of them, with roughly 0.7% having true glandular enlargement unrelated to excess weight. The reassuring part: 75 to 90% of pubertal cases resolve on their own within one to three years, and only about 10% of boys still have it by age 17.
Excess Body Fat: A Different Problem That Looks the Same
Not all enlarged male chests involve actual breast tissue. Pseudogynecomastia is the buildup of fat in the chest area without any glandular growth. It looks similar from the outside, but the underlying cause is simply excess body weight rather than a hormonal imbalance driving tissue development. Losing weight can reduce pseudogynecomastia, while true gynecomastia typically won’t disappear with fat loss alone.
That said, the two can overlap. Higher body fat increases aromatase activity, which converts more testosterone to estrogen. So being overweight can contribute to genuine glandular growth on top of the fat deposits.
Medications That Can Trigger Breast Growth
At least 49 medications have been linked to gynecomastia. It typically shows up as a painful or tender swelling, often on one side, and tends to be temporary. Some of the more commonly reported culprits include:
- Spironolactone, a blood pressure and heart failure drug. It causes bilateral, painless breast enlargement that’s dose-dependent, meaning higher doses carry more risk.
- Finasteride, used for hair loss and enlarged prostate. It blocks the conversion of testosterone to a more potent form, which can alter the estrogen-to-testosterone ratio.
- Certain antidepressants, including fluoxetine (Prozac), paroxetine (Paxil), and venlafaxine (Effexor).
- Proton pump inhibitors and some anti-nausea medications.
- Hormonal treatments used for prostate cancer, which directly suppress testosterone.
If you’ve noticed breast changes after starting a new medication, that timing is worth mentioning to your prescriber. In many cases, the swelling resolves after switching to a different drug.
Anabolic Steroids, Alcohol, and Cannabis
Anabolic steroid use is one of the most common causes in younger men outside of puberty. When you flood the body with synthetic testosterone, aromatase converts the excess into estrogen. The result is the exact opposite of what most steroid users intend. The breast growth can persist even after stopping use, especially if it’s gone on long enough for the tissue to become fibrous.
Alcohol contributes through multiple pathways. Heavy drinking damages the liver, which impairs its ability to clear estrogen from the bloodstream. Chronic alcohol use can also directly suppress testosterone production in the testes.
Cannabis has been linked to gynecomastia through a mechanism that blocks testosterone’s effects at the receptor level. The evidence is less robust than for steroids or alcohol, but the association appears in clinical literature, and adolescents who use marijuana regularly are generally considered at higher risk.
Health Conditions That Shift the Hormone Balance
Several underlying medical conditions can cause gynecomastia by disrupting hormone levels in different ways.
Liver cirrhosis impairs the organ’s ability to process hormones properly. The damaged liver produces more of the protein that binds testosterone, leaving less free testosterone available. It may also fail to clear estrogen precursors, leading to increased estrogen production in fat and other tissues.
Kidney failure, particularly end-stage disease, can reduce testosterone production directly. The testes underperform, and the hormonal balance shifts toward estrogen dominance.
An overactive thyroid (hyperthyroidism) triggers breast growth through several overlapping mechanisms. Thyroid hormones boost aromatase activity, which converts more testosterone to estrogen. They also increase production of the protein that preferentially binds testosterone. The net effect is a higher ratio of free estrogen to free testosterone, even when total testosterone levels appear normal on a blood test.
When It Becomes Permanent
One important detail many people don’t know: breast tissue that’s been present for more than about 12 months undergoes a structural change. The glandular tissue becomes fibrous and hardened through a process called remodeling. Once this happens, no medication or lifestyle change will make it go away. At that point, surgical removal is the only option for reducing the breast size.
This is why timing matters. If caught within the first several months, medication that blocks estrogen’s effects on breast tissue can produce regression in up to 80% of patients. But that window closes. After a year, the tissue is essentially permanent without surgery.
How Treatment Works
For gynecomastia that hasn’t yet become fibrous, the first step is addressing whatever caused the imbalance. That might mean adjusting medications, treating a thyroid problem, losing weight, or stopping steroid use. If that’s not enough, estrogen-blocking medication taken daily for up to three months has shown strong results in shrinking the tissue.
For persistent cases, the approach depends on severity. Mild to moderate enlargement without excess skin is typically treated with liposuction or a minor surgical procedure to remove the gland through a small incision around the nipple. More advanced cases with significant enlargement and sagging skin may require a more extensive procedure similar to a breast reduction. The decision to pursue surgery is based on how much physical discomfort or psychological distress the condition is causing, not on any strict medical threshold.